Jefferies & Co Initiates Coverage on Salix Pharmaceuticals (SLXP) with a Buy

February 1, 2010 8:20 AM EST Send to a Friend
Jefferies & Co initiates coverage on Salix Pharmaceuticals (Nasdaq: SLXP) with a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login